Redefining complex PCI: impact of real-world data and novel evidence on IV antithrombotic strategies
Sponsored by Chiesi Farmaceutici
Pharmacology
Other coronary interventions
Symposium
Room 252A
Anchorperson: Jolanta Siller-Matula
Spokesperson: Dominick Angiolillo
Discussants: Davide Cao, Guy Friedrich, Roxana Mehran, Jennifer Rymer
Watch this session if you want
- To evaluate real-world evidence on antithrombotic strategies in clinical practice across Europe and USA
- To analyse outcomes associated with the transition from cangrelor to oral P2Y12 inhibitors
- To discuss implications of the findings on real-world evidence on state-of-the-art IV therapies in 2025
Welcome and session objectives
Jolanta Siller-Matula
Clinical case: urgent PCI on STEMI patient
Guy Friedrich
ARECA registry
Guy Friedrich
Discussion and audience interaction
Clinical case: a STEMI case presenting with cardiogenic shock
Jennifer Rymer
CAMEO registry
Jennifer Rymer
Discussion and audience interaction
Clinical case: timing and transition protocols to oral P2Y12s
Roxana Mehran
SMILE registry
Roxana Mehran
Discussion and audience interaction
Future insights: IV therapies in 2025
Davide Cao
Discussion and audience interaction
Session evaluation and key learnings
Dominick Angiolillo
